rs1469697

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000540.3(RYR1):​c.7836-66A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 682 hom., cov: 0)
Exomes 𝑓: 0.10 ( 5409 hom. )
Failed GnomAD Quality Control

Consequence

RYR1
NM_000540.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: -0.635

Publications

3 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • RYR1-related myopathy
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 19-38502814-A-G is Benign according to our data. Variant chr19-38502814-A-G is described in ClinVar as Benign. ClinVar VariationId is 133213.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.234 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR1NM_000540.3 linkc.7836-66A>G intron_variant Intron 48 of 105 ENST00000359596.8 NP_000531.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR1ENST00000359596.8 linkc.7836-66A>G intron_variant Intron 48 of 105 5 NM_000540.3 ENSP00000352608.2

Frequencies

GnomAD3 genomes
AF:
0.198
AC:
9752
AN:
49360
Hom.:
679
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.193
Gnomad AMI
AF:
0.300
Gnomad AMR
AF:
0.245
Gnomad ASJ
AF:
0.161
Gnomad EAS
AF:
0.133
Gnomad SAS
AF:
0.233
Gnomad FIN
AF:
0.129
Gnomad MID
AF:
0.173
Gnomad NFE
AF:
0.200
Gnomad OTH
AF:
0.207
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.103
AC:
64505
AN:
626418
Hom.:
5409
Cov.:
9
AF XY:
0.109
AC XY:
34400
AN XY:
315600
show subpopulations
African (AFR)
AF:
0.125
AC:
1284
AN:
10302
American (AMR)
AF:
0.215
AC:
3877
AN:
18032
Ashkenazi Jewish (ASJ)
AF:
0.119
AC:
1685
AN:
14164
East Asian (EAS)
AF:
0.144
AC:
2932
AN:
20306
South Asian (SAS)
AF:
0.211
AC:
8800
AN:
41702
European-Finnish (FIN)
AF:
0.136
AC:
2309
AN:
16986
Middle Eastern (MID)
AF:
0.112
AC:
229
AN:
2050
European-Non Finnish (NFE)
AF:
0.0840
AC:
39992
AN:
475978
Other (OTH)
AF:
0.126
AC:
3397
AN:
26898
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.412
Heterozygous variant carriers
0
2016
4033
6049
8066
10082
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
504
1008
1512
2016
2520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.198
AC:
9771
AN:
49382
Hom.:
682
Cov.:
0
AF XY:
0.199
AC XY:
4606
AN XY:
23140
show subpopulations
African (AFR)
AF:
0.193
AC:
1828
AN:
9448
American (AMR)
AF:
0.246
AC:
1237
AN:
5038
Ashkenazi Jewish (ASJ)
AF:
0.161
AC:
237
AN:
1470
East Asian (EAS)
AF:
0.134
AC:
213
AN:
1592
South Asian (SAS)
AF:
0.236
AC:
290
AN:
1228
European-Finnish (FIN)
AF:
0.129
AC:
354
AN:
2752
Middle Eastern (MID)
AF:
0.186
AC:
19
AN:
102
European-Non Finnish (NFE)
AF:
0.200
AC:
5311
AN:
26604
Other (OTH)
AF:
0.208
AC:
142
AN:
682
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
294
589
883
1178
1472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.376
Hom.:
266

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
-
RYR1 database
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Aug 07, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.31
DANN
Benign
0.24
PhyloP100
-0.64
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1469697; hg19: chr19-38993454; COSMIC: COSV62088836; API